Azcarate P, Zhang A, Keyhani S, Steigerwald S, Ishida J, Cohen B. Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population. J Gen Intern Med. 2020;35(7):1979–86.

PubMed  PubMed Central  Article  Google Scholar 

Dai H, Richter KP. A national survey of marijuana use among US adults with medical conditions, 2016–2017. JAMA Netw Open. 2019;2(9):e1911936.

PubMed  PubMed Central  Article  Google Scholar 

Fitzcharles M-A, Rampakakis E, Sampalis J, Shir Y, Cohen M, Starr M, et al. Medical Cannabis use by rheumatology patients following recreational legalization: a prospective observational Study of 1000 patients in Canada. ACR Open Rheumatol. 2020;2(5):286–93.

PubMed  PubMed Central  Article  Google Scholar 

Fitzcharles M-A, Rampakakis E, Shir Y, Sampalis J, Cohen M, Starr M, et al. Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a prospective cross-sectional study. Clin Exp Rheumatol.  2021;39 Suppl 130(3):115–9.

Gavigan K, Venkatachalam S, Curtis J, Wiedmeyer C, Sydnor-Campbell T, Stake C, et al. Legal matters: attitudes regarding marijuana for medical use among patients with rheumatic and musculoskeletal disease [abstract]. Arthritis Rheumatol. 2019;71(10). https://acrabstracts.org/abstract/legal-matters attitudes-regarding-marijuana-for-medical-use-among-patients-with-rheumatic-and musculoskeletal-disease/. Accessed 29 March 2022. 

Rampakakis E, Shir Y, Sampalis J, Cohen M, Starr M, Häuser W, Fitzcharles M. Medical cannabis in ankylosing spondylitis following recreational legalization: a prospective cross-sectional study [abstract]. Arthritis Rheumatol. 2020;72(10). https://acrabstracts.org/abstract/medical-cannabis-in-ankylosing spondylitis-following-recreational-legalization-a-prospective-cross-sectional-study/. Accessed 29 March 2022. 

Fitzcharles M-A, Häuser W. Cannabinoids in the management of musculoskeletal or rheumatic diseases. Curr Rheumatol Rep. 2016;18(12):76.

PubMed  Article  CAS  Google Scholar 

Fitzcharles MA, Ste-Marie PA, Häuser W, Clauw DJ, Jamal S, Karsh J, et al. Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials. Arthritis Care Res (Hoboken). 2016;68(5):681–8.

CAS  Article  Google Scholar 

Sarzi-Puttini P, Ablin J, Trabelsi A, Fitzcharles MA, Marotto D, Häuser W. Cannabinoids in the treatment of rheumatic diseases: pros and cons. Autoimmun Rev. 2019;18(12):102409.

PubMed  Article  CAS  Google Scholar 

Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers. 2007;4(8):1614–48.

CAS  PubMed  Article  Google Scholar 

DEA announces actions related to marijuana and industrial hemp [press release]. U. S. Drug Enforcement Agency. 2016.

FDA and cannabis: research and drug approval process. US Food and Drug Administration. Updated October 1, 2020. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process#:~:text=The%20agency%20has%2C%20however%2C%20approved,from%20a%20licensed%20healthcare%20provider. Accessed 29 March 2022.

Solutions DG. Map of Marijuana Legality by State. Disa.com. 2021.  https://disa.com/map-of-marijuana-legality-by-state. Accessed 29 March 2022.

Americans for Safe Access. Federal Marijuana Law 2018. https://www.safeaccessnow.org/federal_marijuana_law. Accessed 29 March 2022.

Lampe JR. State marijuana “legalization” and federal drug law: a brief overview for congress. 2020. https://sgp.fas.org/crs/misc/LSB10482.pdf. Accessed 29 March 2022.

Han B, Compton WM, Blanco C, Jones CM. Trends in and correlates of medical marijuana use among adults in the United States. Drug Alcohol Depend. 2018;186:120–9.

PubMed  Article  Google Scholar 

Wipfler K, Shaw Y, Simon T, Cornish A, England B, Ogdie A, et al. Experiences of patients with rheumatic diseases in the US during the early months of the COVID-19 pandemic [abstract]. Arthritis Rheumatol. 2020;72(10). https://acrabstracts.org/abstract/experiences-of-patients-with-rheumatic-diseases-in the-us-during-the-early-months-of-the-covid-19-pandemic/. Accessed 29 March 2022. 

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); January 12, 2017.

Wipfler K, Simon T, Katz P, Wolfe F, Michaud K. Cannabis use among patients in a large US rheumatic disease registry [abstract]. Arthritis Rheumatol. 2019;71(10). Accessed 29 March 2022. https://acrabstracts.org/abstract/cannabis-use-among-patients-in-a-large-us-rheumatic-disease-registry/.

U.S. voter support for marijuana hits new high; Quinnipiac University National poll finds; 76 percent say their finances are excellent or good [press release]. Quinnipiac University-Poll. 2017.  Accessed 29 March 2022. https://poll.qu.edu/Poll-Release-Legacy?releaseid=2453

Swift A. Support for legal marijuana use up to 60% in U.S. Gallup. Gallup. 2016. Accessed March 29, 2022.  https://news.gallup.com/poll/196550/support-legal-marijuana.aspx.

Wipfler K, Simon TA, Katz P, Wolfe F, Michaud K. Increase in cannabis use among adults with rheumatic diseases: results from a 2014-2019 US observational study [published online ahead of print, 2021 Jul 15]. Arthritis Care Res (Hoboken). 2021; https://doi.org/10.1002/acr.24752

Gavigan K, Venkatachalam S, Curtis J, Wiedmeyer C, Sydnor-Campbell T, Stake C, et al editors. Legal matters: attitudes regarding marijuana for medical use among patients with rheumatic and musculoskeletal disease. Atlanta: American College of Rheumatology; 2019.

Google Scholar 

Evanoff AB, Quan T, Dufault C, Awad M, Bierut LJ. Physicians-in-training are not prepared to prescribe medical marijuana. Drug Alcohol Depend. 2017;180:151–5.

PubMed  PubMed Central  Article  Google Scholar 

Fitzcharles M-A, Clauw DJ, Ste-Marie PA, Shir Y. The dilemma of medical marijuana use by rheumatology patients. Arthritis Care Res. 2014;66(6):797–801.

Article  Google Scholar 

Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain–United States, 2016. JAMA. 2016;315(15):1624–45.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Genova A, Dix O, Thakur M, Sangha PS. Chronic non-cancer pain management and addiction: a review. Cureus. 2020;12(2):e6963.

PubMed  PubMed Central  Google Scholar 

Shraim MA, Massé-Alarie H, Hodges PW. Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: a systematic review. Pain. 2021;162(4):1007–37.

CAS  PubMed  Article  Google Scholar 

Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3(3):CD012182. https://doi.org/10.1002/14651858.CD012182.pub2

Bartlett SJ, Hewlett S, Bingham CO, Woodworth TG, Alten R, Pohl C, et al. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis. 2012;71(11):1855.

PubMed  Article  Google Scholar 

Bucourt E, Martaillé V, Goupille P, Joncker-Vannier I, Huttenberger B, Réveillère C, et al. A comparative study of fibromyalgia, rheumatoid arthritis, spondyloarthritis, and Sjögren’s syndrome; impact of the disease on quality of life, psychological adjustment, and use of coping strategies. Pain Med. 2021;22(2):372–81.

PubMed  Article  Google Scholar 

Galvez-Sánchez CM, Montoro CI, Duschek S, Del Paso GAR. Pain catastrophizing mediates the negative influence of pain and trait-anxiety on health-related quality of life in fibromyalgia. Qual Life Res. 2020;29(7):1871–81.

PubMed  Article  Google Scholar 

Nowell WB, Gavigan K, Kannowski CL, Cai Z, Hunter T, Venkatachalam S, et al. Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower. Arthritis Res Ther. 2021;23(1):53.

PubMed  PubMed Central  Article  Google Scholar 

Walker HK, Hall WD, Hurst JW eds. Clinical methods: the history, physical, and laboratory examinations, 3rd ed. Boston: Butterworths. 1990.

Murphy SL, Phillips K, Williams DA, Clauw DJ. The role of the central nervous system in osteoarthritis pain and implications for rehabilitation. Curr Rheumatol Rep. 2012;14(6):576–82.

CAS  PubMed  Article  Google Scholar 

Aghazadeh Tabrizi M, Baraldi PG, Borea PA, Varani K. Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists. Chem Rev. 2016;116(2):519–60.

CAS  PubMed  Article  Google Scholar 

Barrie N, Manolios N. The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease. Eur J Rheumatol. 2017;4(3):210–8.

PubMed  PubMed Central  Article  Google Scholar 

Chiurchiù V, Lanuti M, Catanzaro G, Fezza F, Rapino C, Maccarrone M. Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. Atherosclerosis. 2014;233(1):55–63.

PubMed  Article  CAS  Google Scholar 

Gui H, Tong Q, Qu W, Mao CM, Dai SM. The endocannabinoid system and its therapeutic implications in rheumatoid arthritis. Int Immunopharmacol. 2015;26(1):86–91.

CAS  PubMed  Article  Google Scholar 

Huang L, Quinn MA, Frampton GA, Golden LE, DeMorrow S. Recent advances in the understanding of the role of the endocannabinoid system in liver diseases. Dig Liver Dis. 2011;43(3):188–93.

CAS  PubMed  Article  Google Scholar 

Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013;17(4):475–90.

CAS  PubMed  Article  Google Scholar 

You T, Disanzo BL, Wang X, Yang R, Gong D. Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise. Lipids Health Dis. 2011;10:194.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Barrie N, Kuruppu V, Manolios E, Ali M, Moghaddam M, Manolios N. Endocannabinoids in arthritis: current views and perspective. Int J Rheum Dis. 2017;20(7):789–97.

PubMed  Article  Google Scholar 

Bouchet CA, Ingram SL. Cannabinoids in the descending pain modulatory circuit: role in inflammation. Pharmacol Ther. 2020;209:107495.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cravatt BF, Lichtman AH. The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol. 2004;61(1):149–60.

CAS  PubMed  Article  Google Scholar 

Fukuda S, Kohsaka H, Takayasu A, Yokoyama W, Miyabe C, Miyabe Y, et al. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. BMC Musculoskelet Disord. 2014;15:275.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci. 1995;56(23–24):2103–9.

CAS  PubMed  Article  Google Scholar 

Morena M, Patel S, Bains JS, Hill MN. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology. 2016;41(1):80–102.

CAS  PubMed  Article  Google Scholar 

Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A. 2003;100(18):10529–33.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Di Marzo V, De Petrocellis L. Why do cannabinoid receptors have more than one endogenous ligand? Philos Trans R Soc B Biol Sci. 2012;367(1607):3216–28.

Article  CAS  Google Scholar 

Schaible HG, von Banchet GS, Boettger MK, Bräuer R, Gajda M, Richter F, et al. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci. 2010;1193:60–9.

CAS  PubMed  Article  Google Scholar 

Ligresti A, De Petrocellis L, Di Marzo V. From Phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology. Physiol Rev. 2016;96(4):1593–659.